Risultati della ricerca

• 21. bando_bs_15-2024_scichilone (22%)

  2-feb-2024 10.25.08

  Preclinico dal titolo “Ex vivo 3D model of T2-asthma and the effects of dupilumab”, sottoscritto dalla ... Sanofi Srl – PROMISE, studio “Ex vivo 3D model of T2-asthma and the effects of dupilumab”, Codice ... su: Contratto Sanofi Srl – PROMISE, studio “Ex vivo 3D model of T2-asthma and the effects of dupilumab ... studio “Ex vivo 3D model of T2-asthma and the effects of dupilumab”, Codice Progetto

• 22. bando_bs_123-2019_scichilone_ftolf (19%)

  4-dic-2019 9.44.23

  , da far gravare su fondi GSK - Call 2018, Innovation in severe refractory asthma - Codice: R4D04-ASS ... refractory asthma - Codice: R4D04-ASS- RIC-GLAXO-SCICHI-2018; Responsabile Scientifico: Prof. Nicola ... complessità.”, da far gravare su fondi GSK - Call 2018, Innovation in severe refractory asthma - Codice

• 23. TRIAL 2020 (19%)

  13-dic-2022 14.49.14

  TRIAL 2020 articolo, notizia, unipa Elenco Trial - Anno 2020 Elenco Schede TRIAL - Anno 2020 Title Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients NCT Number NCT04181190 Conditions Asthma|Asthma; Eosinophilic Interventions Diagnostic Test: Total IgE|Diagnostic Test: Blood cell counts|Diagnostic Test: Asthma control assessment|Diagnostic Test: lung function tests Sponsor/Collaborators Università degli Studi di Ferrara Gender All Age Child, Adult, Older

• 24. Trial 2020 (19%)

  16-dic-2022 16.39.02

  TRIAL 2020 articolo, notizia, unipa Elenco Trial - Anno 2020 Elenco Schede TRIAL - Anno 2020 Title Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients NCT Number NCT04181190 Conditions Asthma|Asthma; Eosinophilic Interventions Diagnostic Test: Total IgE|Diagnostic Test: Blood cell counts|Diagnostic Test: Asthma control assessment|Diagnostic Test: lung function tests Sponsor/Collaborators Università degli Studi di Ferrara Gender All Age Child, Adult, Older

• 25. Trial approvati da Comitato Etico (19%)

  15-dic-2023 20.50.37

  /05/2023 The Basa Study: Breathanalysis For Severe Asthma Patients. A New, Non Invasive Approach For The Monitoring Of Infiammation In Severe Asthma Patients On Biologics Dott. Stefania Principe U.O.C ... (De-Escalation In Severe Asthma, Desa) Dott.ssa Alida Benfante U.O.C. di Pneumologia 17/05/2023 Intrappolati

• 26. Progetti approvati dal Comitato Etico Palermo 1 (19%)

  15-feb-2024 11.40.40

  : Breathanalysis For Severe Asthma Patients. A New, Non Invasive Approach For The Monitoring Of Infiammation In Severe Asthma Patients On Biologics Dott. Stefania Principe U.O.C. di Pneumologia 17/05/2023 ... ) E Anticorpo Monoclonale Anti Il-5R (Benralizumab ) In Remissione Di Malattia (De-Escalation In Severe Asthma

• 27. commissione_bs_123-2019_scichilone_ftolf (18%)

  5-feb-2020 9.00.08

  gravare su fondi GSK - Call 2018, Innovation in severe refractory asthma - Codice: R4D04-ASS-RIC ... , Innovation in severe refractory asthma - Codice: R4D04-ASS-RIC-GLAXO-SCICHI-2018; Responsabile

• 28. Palermo University Prize ad Alkis Togias (18%)

  26-apr-2017 13.31.13

  “Current Understanding and Future Approaches for Severe Childhood Asthma”. Il Prof. Togias è ... of Health oltre che Branch Chief della Allergy, Asthma and Airway Biology (AAABB), Division

• 29. commissione_bs 15-2024 scichilone (18%)

  29-mar-2024 9.43.45

  gravare su Contratto Sanofi Srl – PROMISE, studio “Ex vivo 3D model of T2-asthma and the effects ... grave”, da far gravare su Contratto Sanofi Srl – PROMISE, studio “Ex vivo 3D model of T2-asthma and

• 30. Trial (16%)

  15-dic-2023 20.38.41

  https://clinicaltrials.gov/study/NCT04770896 Title The BASA Study: Breath Analysis for Severe Asthma Patients. A New, Non-invasive Approach for the Monitoring of Inflammation in Severe Asthma Patients on Biologics NCT Number NCT05946421 Conditions Intervention/treatment Severe Asthma Interventions

• 31. Trial in corso (16%)

  18-mar-2024 8.04.43

• 32. De Vries et al 2012_Alexithymia in cancer patients (16%)

  4-feb-2019 9.55.40

  ] and stress-related disorders in general [ 15] , asthma tients with cancer deserves more systematic ... . near-fatal asthma. Eur Respir J 2006; 28: 296– 31 Bagby RM, Parker JDA, Taylor GR: Dimen- 3

• 33. cv_daniele (16%)

  8-apr-2021 13.35.32

  , D’Agostino B, Mazzarella G, Bianco A “Adiponectin in Asthma: Implications for Phenotyping” Current ... , Daniele A. The burden of obesity in asthma and COPD: Role of adiponectin Pulm Pharmacol Ther. 2017;43

• 34. cv prof. quaranta (16%)

  6-apr-2022 11.17.35

  , Quaranta N. Allergic and non-allergic rhinitis: relationship with nasal polyposis, asthma and family ... in children? Curr Allergy Asthma Rep 2014; 14:472 88. Bernabei R, Bonuccelli U, Maggi S, Marengoni

• 35. Trial conclusi (16%)

  7-feb-2024 12.56.20

  Assessed by HRCT in severe asthma (BREATH Study) Il ruolo del Benralizumab sul rimodellamento delle vie ... -16-12340 (Sponsor's Protocol Code Number) Conditions SEVERE ASTHMA Interventions Sponsor

• 36. Trial conclusi (16%)

  15-feb-2024 9.19.10

  Assessed by HRCT in severe asthma (BREATH Study) Il ruolo del Benralizumab sul rimodellamento delle vie ... -16-12340 (Sponsor's Protocol Code Number) Conditions SEVERE ASTHMA Interventions Sponsor

• 37. Progetti di ricerca 2020 (16%)

  18-mar-2024 8.31.54

  2018 2019 Prof. Stefania Grimaudo € 3.360,00 Innovation in severe refractory asthma 2019 Prof. Nicola ... of Benralizumab on airway REmodeling Assessed by HRCT in severe asTHma: The BREATH Study, co-finanziato da Astra

• 38. Progetti di ricerca (16%)

  18-mar-2024 8.31.56

  . Stefania Grimaudo € 3.360,00 Innovation in severe refractory asthma 2019 Prof. Nicola Scichilone ... REmodeling Assessed by HRCT in severe asTHma: The BREATH Study, co-finanziato da Astra Zeneca Prof

• 39. cv_cuzzocrea (13%)

  5-mar-2021 9.48.41

  ) A comparative analysis of interaction between parents and children affected by diabetes or asthma

• 40. cv prof. nicolai (13%)

  6-apr-2022 11.17.34